{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:46:15Z","timestamp":1790005575410,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05745-8","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:29:07Z","timestamp":1730107747000},"page":"3079-3085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patients with systemic sclerosis frequently use phytopharmaceuticals: a cross-sectional survey"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-0591","authenticated-orcid":false,"given":"Tuba Demirci","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-1139","authenticated-orcid":false,"given":"Fatma","family":"Basibuyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-9307","authenticated-orcid":false,"given":"A. Merih","family":"Birlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"11","key":"5745_CR1","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1136\/annrheumdis-2013-204424","volume":"65","author":"F Van den Hoogen","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) Classification criteria for systemic sclerosis: an ACR-EULAR Collaborative Initiative. Arthritis Rheum 65(11):2737\u20132747. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Arthritis Rheum"},{"issue":"11","key":"5745_CR2","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","volume":"76","author":"M Elhai","year":"2017","unstructured":"Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A et al (2017) Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76(11):1897\u20131905. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211448","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5745_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12016-020-08831-4","volume":"62","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wu J, Wu H, Sawalha AH, Lu Q (2021) Clinical treatment options in Scleroderma: recommendations and Comprehensive Review. Clin Rev Allergy Immunol 62(2):273\u2013291. https:\/\/doi.org\/10.1007\/s12016-020-08831-4","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"5745_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/2397198319833503","volume":"4","author":"K Showalter","year":"2019","unstructured":"Showalter K, Hoffmann A, DeCredico N, Thakrar A, Arroyo E, Goldberg I, Hinchcliff M (2019) Complementary therapies for patients with systemic sclerosis. J Scleroderma Relat Disord 4(3):187\u2013199. https:\/\/doi.org\/10.1177\/2397198319833503","journal-title":"J Scleroderma Relat Disord"},{"issue":"4","key":"5745_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.explore.2008.04.004","volume":"4","author":"SE Hunnicutt","year":"2008","unstructured":"Hunnicutt SE, Grady J, McNearney TA (2008) Complementary and alternative medicine use was associated with higher perceived physical and mental functioning in early systemic sclerosis. Explore (NY) 4(4):259\u2013263. https:\/\/doi.org\/10.1016\/j.explore.2008.04.004","journal-title":"Explore (NY)"},{"issue":"11","key":"5745_CR6","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00296-023-05384-5","volume":"43","author":"T Demirci Yildirim","year":"2023","unstructured":"Demirci Yildirim T, Y\u0131ld\u0131r\u0131m S, Birlik AM (2023) Rheumatological patients\u2019 knowledge of, beliefs about, and practices in using phytotherapy: an exploratory study. Rheumatol Int 43(11):2125\u20132130. https:\/\/doi.org\/10.1007\/s00296-023-05384-5","journal-title":"Rheumatol Int"},{"issue":"9","key":"5745_CR7","doi-asserted-by":"publisher","first-page":"e0257319","DOI":"10.1371\/journal.pone.0257319","volume":"16","author":"CI Caballero-Hern\u00e1ndez","year":"2021","unstructured":"Caballero-Hern\u00e1ndez CI, Gonz\u00e1lez-Ch\u00e1vez SA, Urenda-Quezada A, Reyes-Cordero GC, Pel\u00e1ez-Ballestas I, \u00c1lvarez-Hern\u00e1ndez E, Pacheco-Tena C (2021) Prevalence of complementary and alternative medicine despite limited perceived efficacy in patients with rheumatic diseases in Mexico: cross-sectional study. PLoS ONE 16(9):e0257319. https:\/\/doi.org\/10.1371\/journal.pone.0257319","journal-title":"PLoS ONE"},{"issue":"48","key":"5745_CR8","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.3346\/jkms.2023.38.e403","volume":"38","author":"O Zimba","year":"2023","unstructured":"Zimba O, Gasparyan AY (2023) Designing, conducting, and reporting Survey studies: a primer for researchers. J Korean Med Sci 38(48):e403. https:\/\/doi.org\/10.3346\/jkms.2023.38.e403","journal-title":"J Korean Med Sci"},{"issue":"1","key":"5745_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12906-023-04327-8","volume":"24","author":"SR M\u00f8ller","year":"2024","unstructured":"M\u00f8ller SR, Ekholm O, Christensen AI (2024) Trends in the use of complementary and alternative medicine between 1987 and 2021 in Denmark. BMC Complement Med Ther 24(1):23. https:\/\/doi.org\/10.1186\/s12906-023-04327-8","journal-title":"BMC Complement Med Ther"},{"key":"5745_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/19325037.2023.2297278","volume":"55","author":"A Versnik Nowak","year":"2024","unstructured":"Versnik Nowak A, Mohawk C, Harris A, Warmka C (2024) Trends in Complementary Health Approach Use among U.S. College students: a systematic review and Meta-Analytic comparison, 2012\u20132023. Am J Heal Educ 55:137\u2013149. https:\/\/doi.org\/10.1080\/19325037.2023.2297278","journal-title":"Am J Heal Educ"},{"key":"5745_CR11","doi-asserted-by":"publisher","unstructured":"Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos-Rey K, Vas J, von Ammon K, Hegyi G, Dragan S, Uehleke B, F\u00f8nneb\u00f8 V, Lewith G (2012) A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementmed 19 Suppl 218\u201328. https:\/\/doi.org\/10.1159\/000342708","DOI":"10.1159\/000342708"},{"issue":"4","key":"5745_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/1403494817733869","volume":"46","author":"LM Kemppainen","year":"2018","unstructured":"Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH (2018) Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants. Scand J Public Health 46(4):448\u2013455. https:\/\/doi.org\/10.1177\/1403494817733869","journal-title":"Scand J Public Health"},{"issue":"15","key":"5745_CR13","doi-asserted-by":"publisher","first-page":"24401","DOI":"10.18632\/oncotarget.14224","volume":"8","author":"M Berretta","year":"2017","unstructured":"Berretta M, Della Pepa C, Tralongo P, Fulvi A, Martellotta F, Lleshi A et al (2017) Use of complementary and alternative medicine (CAM) in cancer patients: an Italian multicenter survey. Oncotarget 8(15):24401\u201324414. https:\/\/doi.org\/10.18632\/oncotarget.14224","journal-title":"Oncotarget"},{"issue":"9","key":"5745_CR14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00228-021-03097-x","volume":"77","author":"AS Alzahrani","year":"2021","unstructured":"Alzahrani AS, Price MJ, Greenfield SM, Paudyal V (2021) Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol 77(9):1259\u20131274. https:\/\/doi.org\/10.1007\/s00228-021-03097-x","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"5745_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12906-021-03416-w","volume":"21","author":"MC Lu","year":"2021","unstructured":"Lu MC, Lo HC, Chang HH, Hsu CW, Koo M (2021) Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study. BMC Complement Med Ther 21(1):247. https:\/\/doi.org\/10.1186\/s12906-021-03416-w","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"5745_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12906-020-03157-2","volume":"20","author":"M Tangkiatkumjai","year":"2020","unstructured":"Tangkiatkumjai M, Boardman H, Walker DM (2020) Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther 20(1):363. https:\/\/doi.org\/10.1186\/s12906-020-03157-2","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"5745_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00296-022-05267-1","volume":"43","author":"BF Kocyigit","year":"2023","unstructured":"Kocyigit BF, Sagtaganov Z, Yessirkepov M, Akyol A (2023) Assessment of complementary and alternative medicine methods in the management of ankylosing spondylitis, rheumatoid arthritis, and fibromyalgia syndrome. Rheumatol Int 43(4):617\u2013625. https:\/\/doi.org\/10.1007\/s00296-022-05267-1","journal-title":"Rheumatol Int"},{"issue":"3","key":"5745_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000536580","volume":"31","author":"F Couillard","year":"2024","unstructured":"Couillard F, Parreau S, Dumonteil S, Ratti N, Palat S, Bezanahary H, Liozon E, Ly KH, Fauchais AL, Gondran G (2024) Use of complementary and alternative medicine by patients treated for systemic Lupus Erythematosus, primary Sj\u00f6gren\u2019s syndrome, or systemic sclerosis in a French Rural Region. Complement Med Res 31(3):234\u2013240. https:\/\/doi.org\/10.1159\/000536580","journal-title":"Complement Med Res"},{"key":"5745_CR19","doi-asserted-by":"publisher","first-page":"101212","DOI":"10.1016\/j.eujim.2020.101212","volume":"40","author":"P Chaikul","year":"2020","unstructured":"Chaikul P, Sripisut T, Chanpirom S, Ditthawutthikul N (2020) Anti-skin aging activities of green tea (Camelliasinensis (L) Kuntze) in B16F10 melanoma cells and human skin fibroblasts. Eur J Integr Med 40:101212. https:\/\/doi.org\/10.1016\/j.eujim.2020.101212","journal-title":"Eur J Integr Med"},{"key":"5745_CR20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/J.BIOPHA.2017.09.024","volume":"95","author":"M Saeed","year":"2017","unstructured":"Saeed M, Naveed M, Arif M, Kakar MU, Manzoor R, Abd El-Hack ME et al (2017) Green tea (Camellia sinensis) and l-theanine: Medicinal values and beneficial applications in humans-A comprehensive review. Biomed Pharmacother 95:1260\u20131275. https:\/\/doi.org\/10.1016\/J.BIOPHA.2017.09.024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5745_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.56543\/aaeeu.2022.1.1.07","volume":"1","author":"N Gokcen","year":"2022","unstructured":"Gokcen N (2022) Inflamm-Aging: a mechanism of Aging that contributes to the characteristics of skin involvement in systemic sclerosis. Anti-Aging East Europe 1(1):47\u201351. https:\/\/doi.org\/10.56543\/aaeeu.2022.1.1.07","journal-title":"Anti-Aging East Europe"},{"key":"5745_CR22","doi-asserted-by":"publisher","first-page":"560682","DOI":"10.1155\/2012\/560682","volume":"2012","author":"P Oyetakinwhite","year":"2012","unstructured":"Oyetakinwhite P, Tribout H, Baron E (2012) Protective mechanisms of green tea polyphenols in skin. Oxid Med Cell Longev 2012:560682. https:\/\/doi.org\/10.1155\/2012\/560682","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"5745_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5606\/ArchRheumatol.2019.6835","volume":"34","author":"A Ko\u00e7ak","year":"2019","unstructured":"Ko\u00e7ak A, Harmanc\u0131 D, \u00c7avdar Z, Ural C, Birlik M, Sar\u0131o\u011flu S, Y\u0131lmaz O, G\u00fcner Akdo\u011fan G (2019) Antioxidant effect of Epigallocatechin-3-Gallate in a Bleomycin-Induced Scleroderma Model. Arch Rheumatol 34(1):1\u20138. https:\/\/doi.org\/10.5606\/ArchRheumatol.2019.6835","journal-title":"Arch Rheumatol"},{"issue":"4","key":"5745_CR24","doi-asserted-by":"publisher","first-page":"300060519882176","DOI":"10.1177\/0300060519882176","volume":"48","author":"D Giuggioli","year":"2020","unstructured":"Giuggioli D, Lumetti F, Spinella A, Cocchiara E, Sighinolfi G, Citriniti G, Colaci M, Salvarani C, Ferri C (2020) Use of neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis. J Int Med Res 48(4):300060519882176. https:\/\/doi.org\/10.1177\/0300060519882176","journal-title":"J Int Med Res"},{"issue":"3","key":"5745_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/138945011794815356","volume":"12","author":"H Zhou","year":"2011","unstructured":"Zhou H, Beevers S, Huang C S (2011) The targets of curcumin. Curr Drug Targets 12(3):332\u2013347. https:\/\/doi.org\/10.2174\/138945011794815356","journal-title":"Curr Drug Targets"},{"issue":"4","key":"5745_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5483\/bmbrep.2012.45.4.221","volume":"45","author":"DC Kim","year":"2012","unstructured":"Kim DC, Ku SK, Bae JS (2012) Anticoagulant activities of curcumin and its derivative. BMB Rep 45(4):221\u2013226. https:\/\/doi.org\/10.5483\/bmbrep.2012.45.4.221","journal-title":"BMB Rep"},{"issue":"2","key":"5745_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/HNP.0000000000000634","volume":"38","author":"\u0130 G\u00f6kkaya","year":"2024","unstructured":"G\u00f6kkaya \u0130, Ko\u00e7er GG, Renda G (2024) What does a community think about aromatherapy? Holist Nurs Pract 38(2):73\u201384. https:\/\/doi.org\/10.1097\/HNP.0000000000000634","journal-title":"Holist Nurs Pract"},{"key":"5745_CR28","doi-asserted-by":"publisher","first-page":"031","DOI":"10.5606\/TJR.2012.004","volume":"27","author":"H Ulusoy","year":"2012","unstructured":"Ulusoy H, Gucer T, Aksu M, Arslan S, Habiboglu A, Akgol G et al (2012) The Use of complementary and alternative medicine in Turkish patients with rheumatic diseases. Arch Rheumatol 27:031\u2013037. https:\/\/doi.org\/10.5606\/TJR.2012.004","journal-title":"Arch Rheumatol"},{"key":"5745_CR29","doi-asserted-by":"publisher","unstructured":"\u00c7\u0131nar F\u0130, Sinan \u00d6, Y\u0131lmaz S, Ba\u011f\u00e7ivan G, Aydo\u011fan I, Yal\u00e7\u0131n AG, Tekg\u00f6z E, \u00c7\u0131nar M (2021) Use of complementary And alternative medicine in patients with ankylosing spondylitis. Eur J Rheumatol 8(1):20\u201326. https:\/\/doi.org\/10.5152\/eurjrheum.2020.20111","DOI":"10.5152\/eurjrheum.2020.20111"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05745-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T16:06:48Z","timestamp":1733328408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05745-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5745"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05745-8","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}